For patients across Pakistan diagnosed with Retinitis Pigmentosa, conventional treatment options remain largely limited to low-vision aids, carefully monitored vitamin A supplementation, and managing secondary complications such as cataract. Since no established cure yet exists within mainstream ophthalmology, patients frequently look beyond their home country for additional avenues. India has emerged as a leading destination for **Retinitis Pigmentosa treatment for patients from Pakistan**, though it remains important to note that a definitive cure for this inherited condition is still a complex and ongoing pursuit within the medical field.
As part of a broader retinitis pigmentosa treatment plan, stem cell-based intervention has emerged as an area of active clinical interest. Because RP progressively affects the rod and cone photoreceptor cells of the retina, treatment approaches that support the surviving retinal cell population are seen as a meaningful area of exploration, offering patients an additional option to discuss alongside standard low-vision management, rather than a replacement for it.
Within a structured retinitis pigmentosa treatment protocol, Mesenchymal stem cell injections given through the Retro-bulbar route have become a frequently used approach, typically delivered across one or two sessions. This method has demonstrated an encouraging record in supporting retinal cell regeneration in patients with progressive inherited retinal disease, with relevance extending to photoreceptor cells, retinal pigment epithelium, and optic nerve tissue.
Patients from Pakistan exploring Retinitis Pigmentosa treatment are welcome to connect with the Eye Stem Cell Center, which has more than 12 years of focused experience evaluating and treating inherited retinal conditions. Our team reviews each patient’s retinal reports carefully before recommending any course of action.
Eye Stem Cell Center is one of the most trusted providers of Retinitis Pigmentosa treatment in Pakistan.

